Skip to main content

Team Category: Board of Directors

Julie Collins

Julie Collins is a general management and public health expert with deep experience in leading national public health education campaigns. Her career in the public health and public service sector is focused on improving patient outcomes through stellar product performance, clear and relevant content, and communications through the full spectrum of media and distribution channels.

Her work spans across health care professionals, researchers, government agencies, senior executives and shareholders, start-up founders, new digital frontiers, eCommerce, CRM and telehealth. Julie is a builder of new capabilities with a highly collaborative approach that delivers positive results.

Julie holds a Masters of Public Health from New York University and undergraduate degree from the University of Georgia.

John Boyce

In 2013, John was named one of the top 15 Technology Luminaries in Massachusetts by the Boston Business Journal and Mass High Technology.

John is both a genomics and proteomics serial entrepreneur with seven successful exits and a venture capitalist focusing on therapeutics, tools, and diagnostics, specializing in building and positioning companies for either acquisition or an IPO. He has formed two successful venture capital firms – Tiger Gene, seeded by Tiger Management, and 28 Capital, a rebrand and expansion of Tiger Gene.

He has successfully raised over $800MM in funding and amassed >$1.8bn through exits. Before co-founding TigerGene Capital and John’s last exit as a serial entrepreneur, John was President and CEO of Exosome Diagnostics, which he led to a successful $575MM acquisition by Bio-Techne. John is also a Fellow at Harvard University, where he teaches ‘Entrepreneurship and Innovation.’

Lynn Grisco

Lynn Grisco is a healthcare executive and strategic advisor with over two decades of leadership across pharmaceuticals, biotechnology, specialty pharmacy, and patient advocacy. She brings expertise in commercial strategy, patient-centered marketing, and access innovation in CNS, oncology, and rare diseases.

Lynn is the founder & CEO of Grisco Consulting, where she partners with healthcare companies to develop transformative strategies that improve patient outcomes & drive market success. She has held senior leadership roles at Acadia, BMS, and Avadel Pharmaceuticals, leading the HCP marketing launch of Lumryz®, a once-nightly treatment for narcolepsy.

Her passion for sleep health deepened when her daughter was diagnosed with narcolepsy in 2022, igniting her role as a dedicated caregiver, advocate, and changemaker in the sleep community.

Lynn serves as Vice Chair, BOD for Wake Up Narcolepsy & on the BOD for the Florida Cancer Specialists Foundation to advance person-centered care.

Susan Manber

A rare cancer survivor and patient advocate, Sue was dedicated to ensuring radical patient-centricity was at the heart of her past-role as Chief Patient Officer at Publicis Health, a first in health communications. Sue helped found two start-up agencies in the early days of the Internet and DTC communications and has deep health and wellness brand-building experience spanning leading companies in virtually every category. She sees sleep as the critically important third pillar of health and is passionate about fueling sleep health for all.

Sue is in demand as a frequent speaker at Healthcare industry conferences and is frequently published, having been featured most recently at HLTH, in Ad Age, and honored in the 2020 MM&M Hall of Femme, 2022 Reuters Patient Champion, and 2024 HBA Luminary.

Larissa D’Andrea

With over 25 years of experience in the healthcare industry, Larissa is passionate about transforming a system that cares for the sick to one that keeps people well. She is person-centric and purpose-driven, engaging in work that drives better health and has a positive, sustainable impact.

Areas of expertise include Environmental, Social, Governance (ESG) corporate strategy, Government Affairs, Market Access, Clinical Advocacy, Patient Advocacy, Medical Affairs strategy, Regulatory Affairs, Quality Assurance, Commercialization of digital solutions, Digital marketing, impact-oriented content production and immersive installations, and Consumer engagement/campaigns to drive behaviors.

She holds a BS in Biology from UCSD and an MS in Legal Studies from USD, School of Law. Sleep health is a personal focus with both her father and fiancé managing sleep apnea alongside cardiac conditions. Most recently, she held executive roles at ResMed.

Anne Marie Morse

Anne Marie Morse is a neurologist with specialized training in child neurology and sleep medicine. An avid educator, successful leader, thoughtful clinician, and inquisitive researcher, Anne views her most important roles in medicine as being a health care partner, advocate, and changemaker.

Her proven track record and unwavering commitment to evolving healthcare into a patient-directed model that operates across all hours of the day, accounting for sleep health and circadian science across all disciplines, are evident in her development of novel programs such as Sleep to Be Well and Wake Up and Learn.

Both programs focus on meeting people where they are, with information and tools to live as successfully as possible and sleep as restfully as possible. Anne envisions a world where sleep can be acknowledged as the vital sign of health, wellness, and performance that it is designed to be.